tiprankstipranks
Trending News
More News >
Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
US Market

Corbus Pharmaceuticals (CRBP) Technical Analysis

Compare
2,358 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Corbus Pharmaceuticals’s (CRBP) Moving Averages Convergence Divergence (MACD) indicator is 0.28, suggesting Corbus Pharmaceuticals is a Sell.
Corbus Pharmaceuticals’s (CRBP) 20-Day exponential moving average is 6.50, while Corbus Pharmaceuticals’s (CRBP) share price is $8.08, making it a Buy.
Corbus Pharmaceuticals’s (CRBP) 50-Day exponential moving average is 7.28, while Corbus Pharmaceuticals’s (CRBP) share price is $8.08, making it a Buy.

Corbus Pharmaceuticals (CRBP) Pivot Points

Apr 26, 2025, 05:37 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.52
6.94
7.64
8.06
8.76
9.18
9.88
Fibonacci
6.94
7.36
7.63
8.06
8.48
8.75
9.18
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Corbus Pharmaceuticals (CRBP) Moving Averages

Apr 26, 2025, 05:37 PM
Period
Simple
Exponential
MA5
7.36Buy
7.50Buy
MA10
6.66Buy
6.91Buy
MA20
5.98Buy
6.50Buy
MA50
6.61Buy
7.28Buy
MA100
9.59Sell
10.94Sell
MA200
23.44Sell
22.58Sell
Corbus Pharmaceuticals’s (CRBP) 10-Day exponential moving average is 6.91, while Corbus Pharmaceuticals’s (CRBP) share price is $8.08, making it a Buy.
Corbus Pharmaceuticals’s (CRBP) 100-Day exponential moving average is 10.94, while Corbus Pharmaceuticals’s (CRBP) share price is $8.08, making it a Sell.
Corbus Pharmaceuticals’s (CRBP) stock price is $8.08 and Corbus Pharmaceuticals’s (CRBP) 50-day simple moving average is 6.61, creating a Buy signal.
Corbus Pharmaceuticals’s (CRBP) stock price is $8.08 and Corbus Pharmaceuticals’s (CRBP) 100-day simple moving average is 9.59, creating a Sell signal.
Corbus Pharmaceuticals’s (CRBP) stock price is $8.08 and Corbus Pharmaceuticals’s (CRBP) 200-day simple moving average is 23.44, creating a Sell signal.

Corbus Pharmaceuticals (CRBP) Technical Indicators

Apr 26, 2025, 05:37 PM
Name
Value
Implied Action
RSI (14)
69.74
Neutral
STOCH (9,6)
90.22
Sell
STOCHRSI (14)
92.72
Sell
MACD (12,26)
0.28
Sell
ADX (14)
34.44
Neutral
Williams %R
-15.89
Sell
CCI (14)
228.92
Sell
ATR (14)
0.56
-
Ultimate Oscillator
67.99
Neutral
ROC
60.96
Buy
Corbus Pharmaceuticals’s (CRBP) Relative Strength Index (RSI) is 69.74, creating a Neutral signal.
Corbus Pharmaceuticals’s (CRBP) Trend Strength Indicator (ADX) is 34.44, creating a Neutral signal.
Corbus Pharmaceuticals’s (CRBP) Commodity Channel Index (CCI) is 228.92, creating a Sell signal.
Corbus Pharmaceuticals’s (CRBP) Price Rate of Change (ROC) is 60.96, creating a Buy signal.

FAQ

Is CRBP a Buy, Hold, or Sell?
Based on CRBP’s technical indicators, CRBP is a Hold.
    What is CRBP’s RSI (14)?
    CRBP’s RSI (14) is 69.74, which suggests CRBP is a Neutral.
      What is CRBP’s MACD?
      CRBP’s MACD is 0.28, which suggests CRBP is a Sell.
        What is CRBP’s 5-day moving average?
        CRBP’s 5-day moving average is 7.36, which suggests CRBP is a Buy.
          What is CRBP’s 20-day moving average?
          CRBP 20-day moving average is 5.98, which suggests CRBP is a Buy.
            What is CRBP’s 50-day moving average?
            CRBP’s 50-day moving average is 6.61, which suggests CRBP is a Buy.
              What is CRBP’s 200-day moving average?
              CRBP’s 200-day moving average is 23.44, which suggests CRBP is a Sell.
                What is CRBP’s Williams % R (14)?
                CRBP’s Williams % R (14) is -15.89, which suggests CRBP is a Sell.
                  What is CRBP’s CCI (14)?
                  CRBP’s CCI (14) is 228.92, which suggests CRBP is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis